Interestingly, of the tissues of origin investigated, only platelet-derived TF-bearing EVs presented an increase in concentration and percentage in the plasma of the COVID-19 patient (Figures 2C, D), indicating that platelet-derived EVs circulate with abnormal expression of TF, an important activator of the coagulation cascade. This evidence concerns the gene TF and COVID-19.